The DOI matches its Crossref record; 23 of the 23 references it cites were found in a registry or an index.
Ginkgolic Acid Inhibits Protein SUMOylation by Blocking Formation of the E1-SUMO Intermediate
Open accessAbstract
Protein modification by small ubiquitin-related modifier proteins (SUMOs) controls diverse cellular functions. Dysregulation of SUMOylation or deSUMOylation processes has been implicated in the development of cancer and neurodegenerative diseases. However, no small-molecule inhibiting protein SUMOylation has been reported so far. Here, we report inhibition of SUMOylation by ginkgolic acid and its analog, anacardic acid. Ginkgolic acid and anacardic acid inhibit protein SUMOylation both in vitro and in vivo without affecting in vivo ubiquitination. Binding assays with a fluorescently labeled probe showed that ginkgolic acid directly binds E1 and inhibits the formation of the E1-SUMO intermediate. These studies will provide not only a useful tool for investigating the roles of SUMO conjugations in a variety of pathways in cells, but also a basis for the development of drugs targeted against diseases involving aberrant SUMOylation.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Furthermore, the use of anacardic acid, an inhibitor of protein SUMOylation, 16 abrogated pksC E. coliinduced senescence (unpublished data).”
From The bacterial genotoxin colibactin promotes colon tumor growth by modifying the tumor microenvironment (2014) · cites this paper as [16]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Mechanisms Underlying Ubiquitination
Pickart, C. M. (2001) · Annual Review of Biochemistry · doi:10.1146/annurev.biochem.70.1.503 · Cited by 3,184
Johnson, E. S. (2004) · Annual Review of Biochemistry · doi:10.1146/annurev.biochem.73.011303.074118 · Cited by 1,711
Lysine Acetylation: Codified Crosstalk with Other Posttranslational Modifications
Yang, X.-J., & Seto, E. (2008) · Molecular Cell · doi:10.1016/j.molcel.2008.07.002 · Cited by 1,006
SUMO‐1 modification activates the transcriptional response of p53
Rodríguez, M. S., Desterro, J. M. P., Laı́n, S., Midgley, C., Lane, D. P., & Hay, R. T. (1999) · The EMBO Journal · doi:10.1093/emboj/18.22.6455 · Cited by 639
p300/CBP‐mediated p53 acetylation is commonly induced by p53‐activating agents and inhibited by MDM2
Ito, A., Lai, C.-H., Zhao, X., Saito, S., Hamilton, M. H., Appella, E., & Yao, T. (2001) · The EMBO Journal · doi:10.1093/emboj/20.6.1331 · Cited by 597
Self-citationSmall Molecule Modulators of Histone Acetyltransferase p300
Balasubramanyam, K., Swaminathan, V., Ranganathan, A., & Kundu, T. K. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m301580200 · Cited by 518
Activation of p53 by conjugation to the ubiquitin‐like protein SUMO‐1
Gostissa, M., Hengstermann, A., Fogal, V., Sandy, P., Schwarz, S. E., Scheffner, M., & Sal, G. D. (1999) · The EMBO Journal · doi:10.1093/emboj/18.22.6462 · Cited by 512
Inhibitors of Ubiquitin-Activating Enzyme (E1), a New Class of Potential Cancer Therapeutics
Yang, Y., Kitagaki, J., Dai, R., Tsai, Y. C., Lorick, K. L., Ludwig, R. L., Pierre, S. A., Jensen, J. P., Davydov, I. V., Oberoi, P., et al. (2007) · Cancer Research · doi:10.1158/0008-5472.can-07-0568 · Cited by 442
Regulation of SUMOylation by Reversible Oxidation of SUMO Conjugating Enzymes
Bossis, G., & Melchior, F. (2006) · Molecular Cell · doi:10.1016/j.molcel.2005.12.019 · Cited by 406
The emerging field of dynamic lysine methylation of non-histone proteins
Huang, J. L., & Berger, S. L. (2008) · Current Opinion in Genetics & Development · doi:10.1016/j.gde.2008.01.012 · Cited by 296
Cited by
Sorted by citations
Items 301–360 of 360
Exploring the Role that SUMOylation Plays in Regulating CDK2 Function in Cancer Cells
Stephenson, S. (2024) · Queensland University of Technology · doi:10.5204/thesis.eprints.251485 · Cited by 1
A functional analysis of the epigenetic regulator CTCF
Kitchen, N. S. (2010) · Illinois Digital Environment for Access to Learning and Scholarship (University of Illinois at Urbana-Champaign)
Song, Y. (2011) · eScholarship (California Digital Library)
Yukita, A. (2014) · Journal of Oral Biosciences · doi:10.1016/j.job.2014.03.003
Recent Progress of DeSUMOylation in Biological Processes: A Mini Review
Wang, C., & Yang, W. (2012) · North American Journal of Medicine and Science · doi:10.7156/v5i2p071
Thompson, P. J. (2015) · cIRcle (University of British Columbia) · doi:10.14288/1.0221305
Étude de la SUMOylation dans l’immunité innée et l’oncogenèse
Decque, A. (2014) · theses.fr (ABES) · doi:10.70675/9c751457z588az4210za1bbz3b5d58fb2087
Parker, A. R. (2022) · Digital Archive @ GSU · doi:10.57709/11188576
Efficient, Scalable Syntheses of Ginkgolic Acids
Alterman, J. L., & Kraus, G. A. (2019) · Natural Product Communications · doi:10.1177/1934578x19851348
Ito, A., & Yoshida, M. (2017) · Springer eBooks · doi:10.1007/978-4-431-56529-1_3
Self-citationThéry, C., & Segura, É. (2014) · Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature · doi:10.3410/f.718214293.793489767
Ginkgo biloba, DNA Damage and DNA Repair: Overview
de Oliveira, D. B., Johansson, B., & de Oliveira, R. P. S. (2018) · Springer eBooks · doi:10.1007/978-3-319-31143-2_11-2
Dietary and Metabolic Compounds Affecting Covalent Histone Modifications
Davison, G. W. (2022) · Elsevier eBooks · doi:10.1016/b978-0-323-91909-8.00024-4
Yudhananda, A., Listyarini, K., Sumantri, C., & Gunawan, A. (2023) · Buletin Peternakan · doi:10.21059/buletinpeternak.v47i3.84177
Park, M., Cai, M., Thacker, A. T., Roberts, C., Qin, T., & Sakamoto, D. (2023) · Research Square · doi:10.21203/rs.3.rs-3702688/v1
Understanding the role UFMylation plays in prostate cancer
Stephenson, S. (2024) · Queensland University of Technology · doi:10.5204/thesis.eprints.246676
The synthesis of cell signaling molecules
Alterman, J. (2021) · doi:10.31274/td-20240329-788
Liu, H., & Joung, H. (2024) · Molecular Medicine Reports · doi:10.3892/mmr.2024.13328
Structure Activity Relationship Studies of Anacardic Acid Derivatives Targeting Sumo E1Preprint
Kumar, G. B., Padmakumar, S., Melge, A. R., Madhavan, A., Nair, B. G., & Perry, J. J. P. (2024) · SSRN Electronic Journal · doi:10.2139/ssrn.5047965
Codenotti, S., Lauschke, V. M., Casella, E. V., Andersson, D. C., Fanzani, A., & Gastaldello, S. (2025) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2025.01.15.633172
Wang, M. (2025) · International Journal of Clinical and Experimental Medicine · doi:10.62347/jjvs1398
Roh, J., Jang, J., Kim, G.-H., Jang, M., Park, J., Oh, T., Kwon, Y., Ahn, J. S., Jang, J., & Ko, S. (2025) · Biochemical Pharmacology · doi:10.1016/j.bcp.2025.117195
Blockage of SUMO E1 enzyme inhibits ocular lens fibrosis by mediating SMAD4 SUMOylation
Hou, M., Ding, Y. J., Bao, X., Liu, L., Wang, Y., & Wu, M. (2025) · Genes & Diseases · doi:10.1016/j.gendis.2025.101827
SUMO E1 covalent allosteric inhibitors upregulate polyamine synthesis via the MAT2A-AdoMetDC axis
Zhang, S., Li, J., Wang, Z., Jiao, Y., Shi, X., Ai, Y., Wang, J., & Liu, S. (2025) · Bioorganic Chemistry · doi:10.1016/j.bioorg.2025.108930 · Cited by 2
SUMOylation and NEDDylation in kidney diseases
Chen, Z., Li, D., Zhang, J., Wei, B.-Y., Zhao, H., Li, P., & Chen, D. (2025) · Experimental and Molecular Pathology · doi:10.1016/j.yexmp.2025.105010
Gupta, D., Andole, S., & Mishra, K. (2025) · Journal of Computer-Aided Molecular Design · doi:10.1007/s10822-025-00724-y
Zhang, J., Ouyang, F., Gao, A., Zeng, T., Li, M., Li, H., Zhou, W., Gao, Q., Tang, X., Zhang, Q., et al. (2024) · Figshare · doi:10.6084/m9.figshare.25779370
Yang, H.-M., Lee, J.-E., Kim, J.-Y., You, J., Kim, J., Lee, H. S., Yoo, H. M., Kong, M. G., Han, J.-K., Cho, H.-J., et al. (2023) · Figshare · doi:10.6084/m9.figshare.22606547
Chen, Q., Dong, D., Yu, X., Jiang, X., Jiang, H., Hou, J., Wang, L., Xu, J., Wu, X., & Chen, X. (2026) · PLoS neglected tropical diseases · doi:10.1371/journal.pntd.0013497
SUMOylation and anticancer drug resistance
Zhao, H., & Huang, C. (2026) · Biochimie · doi:10.1016/j.biochi.2026.01.007 · Cited by 1
Congener-resolved hazard identification of ginkgolic acids as emerging natural contaminants
Bai, J., Li, H., Zhao, M., Yan, X., Hua, L., Zhang, M., Hongming, C., Zhou, K., & Liu, Y. (2026) · Journal of Hazardous Materials · doi:10.1016/j.jhazmat.2026.141479
Identification of new regulators for PML nuclear bodies
Snollaerts, T. (2016) · theses.fr (ABES) · doi:10.70675/a97a0132zae2fz4278zad92z5e4b56df97b2
ROS/SUMO relationship in the chemotherapeutic treatment of Acute Myeloid Leukemia
Ristic, M. (2015) · theses.fr (ABES) · doi:10.70675/2176c900z3348z4cc3z8402z8c35404016b0
Dassanayake, M. K., Khoo, T.-J., Chong, C. H., Ansari, M. T., Martino, P. D., Zanchi, F. B., Figiel, A., Szumny, A., ElFar, O. A., Wiart, C., et al. (2026) · PLoS ONE · doi:10.1371/journal.pone.0346254
Role of the SUMO pathway in Acute Myeloid Leukemias response to treatments
Baik, H. (2017) · theses.fr (ABES) · doi:10.70675/156a7d66zb325z4965zbd18z8c101e88ebc2
Boulanger, M. (2019) · theses.fr (ABES) · doi:10.70675/18c2cd65z799bz410ezb454z2ecf0d01ec1d
Déterminants viraux et cellulaires de la décapsidation et de l’import nucléaire du VIH-1
Fernandez, J. (2019) · theses.fr (ABES) · doi:10.70675/18f8da43ze621z40dcz8e7cza22a9162e7b2
Pathophysiological consequences of a Fragile X missense mutation
Garcia, M. P. (2020) · theses.fr (ABES) · doi:10.70675/b8e86263z5926z4a83zbaf6z0f61bf2d15f9
ROS–SUMO Crosstalk in Oxidative Stress: Disease Mechanisms and Reproductive Health
Na, A., Lee, H., & Ryu, H. (2026) · Antioxidants · doi:10.3390/antiox15040453
Morel, V. (2021) · theses.fr (ABES) · doi:10.70675/31e506dazce13z4d4cz8c40z9823077c170b
Pathophysiology of the FMRP-R138Q Fragile X Syndrome missense mutation in mice
Chato-Astrain, I. (2025) · theses.fr (ABES) · doi:10.70675/ce8d1ccfz4554z4c55z8782z624e392f72a1
The Role of Epigenetics in Cancer Progression
Biswas, P., Sridhar, B., Saha, A., Sudha, M., & Kulkarni, M. (2026) · BENTHAM SCIENCE PUBLISHERS eBooks · doi:10.2174/9798898814113126010006
Inhibition of SUMOylation by anacardic acid inhibits adaptive immunity and the development of EAE
Kim, K., Ljunggren‐Rose, A., Yarlagadda, M., Vergne, M. J., & Sriram, S. (2026) · International Immunopharmacology · doi:10.1016/j.intimp.2026.116745
The role of SUMOylation in regulating proteins that drive neuronal disease progression
Sidharth, A., & Shin, D. (2026) · Biochemistry and Biophysics Reports · doi:10.1016/j.bbrep.2026.102687
Li, Y., Zhu, Z., & Zhang, K. (2026) · Frontiers in Neuroscience · doi:10.3389/fnins.2026.1885786
Lu, J., Chen, X., Chen, Y., Wang, D., Wu, J., Jin, R., Guo, H., Zhang, Q., Zhao, P., Shi, Y., et al. (2026) · Pharmacological Research · doi:10.1016/j.phrs.2026.108417
Aldeghaither, S. Y., Alfhili, M. A., & Alsughayyir, J. (2026) · Acta Pharmaceutica · doi:10.2478/acph-2026-0026
Dietary and Metabolic Compounds Affecting Chromatin Dynamics/Remodeling
Milagro, F. I., Campión, J., & Martínez, J. A. (2010) · Elsevier eBooks · doi:10.1016/b978-0-12-375709-8.00018-6
Metadata
- Authors
- Fukuda, I., Ito, A., Hirai, G., Nishimura, S., Kawasaki, H., Saitoh, H., Kimura, K.-I., Sodeoka, M., & Yoshida, M.
- Affiliations
- RIKEN Advanced Science Institute (JP)
- Japan Science and Technology Agency (JP)
- RIKEN (JP)
- Tokyo Denki University (JP)
- Institute of Molecular Embryology and Genetics, Kumamoto University (JP)
- Iwate University (JP)
- Corresponding author
- Ito, Akihiro
- ORCID
- Venue
- Chemistry & Biology
- Publisher
- Elsevier BV
- Published
- 2009-02
- Volume
- 16
- Issue
- 2
- Pages
- 133-140
- ISSN
- 1074-5521 (ISSN-L)
- OpenAlex
- W1978693761
- Cited by
- 355
- References
- 23
- Citations by year
- 2026: 14 · 2025: 23 · 2024: 25 · 2023: 23 · 2022: 21 · 2021: 27 · 2020: 28 · 2019: 27 · 2018: 31 · 2017: 30 · 2016: 23 · 2015: 20 · 2014: 31 · 2013: 9 · 2012: 6
- FWCI
- 3.08
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Licence
- Locations
- Chemistry & Biology (publishedVersion)
- PubMed (publishedVersion)
- Institutional Repositories DataBase (IRDB) (submittedVersion)
- Sakura: Saitama United Cyber Repository of Academic Resources (Saitama University) (submittedVersion)
- Funders
- Core Research for Evolutional Science and Technology
- Advanced Science Institute
- Japan Science and Technology Corporation
- Ministry of Education, Culture, Sports, Science and Technology
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Ubiquitin and proteasome pathways
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Protein Degradation and Inhibitors
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Cancer-related gene regulation
- Keywords
- ginkgolic acid, anacardic acid, protein sumoylation, SUMOylation inhibition, small molecule inhibitors, SUMO conjugation, ubiquitination, drug development
- MeSH terms
- Plant Extracts, Protein Binding, Salicylates, Structure-Activity Relationship, Plant Leaves, Ginkgo biloba, Small Ubiquitin-Related Modifier Proteins, Anacardic Acids, Small Molecule Libraries, Ubiquitination
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review